Top Markets
Coin of the day
Genomma Lab Internacional, S.A.B. de C.V. Genomma Lab Internacional, S.A.B. de C.V.

Genomma Lab Internacional, S.A.B. de C.V.

LABB
株式のランク #10943
Genomma Lab Internacional, S.A.B. de C.V., along with its subsidiary companies,... Genomma Lab Internacional, S.A.B. de C.V., along with its subsidiary companies, specializes in the formulation, promotion, and worldwide distribution of non-prescription pharmaceuticals and personal hygiene products. The firm's extensive product range covers areas such as skincare, general health and wellness, haircare, pain management, cold and flu remedies, gastrointestinal treatments, sexual health, antiperspirant deodorants, hand sanitizers, rehydration drinks, and shaving essentials. It also provides analgesics, antifungal solutions, and hemorrhoid treatments. These items are sold under numerous recognized brands, including Cicatricure, Asepxia, Teatrical, Goicoechea, Sistema GB, Medicasp, Tío Nacho, Vanart, Novamil, Ultra Bengue, X-Ray, Tafirol, Alliviax, Bufferin, Next, XL-3, Genoprazol, QG5, Kaopectate, Proctan, Nikzon, Unesia, Silka Medic, lagicam, Suerox, Groomen, DiabetTX, among others. Incorporated in 1996, Genomma Lab Internacional, S.A.B. de C.V. is headquartered in Mexico City, Mexico.
株価
$0.78199085
最終同期: 2026-08-28
時価総額
$764.59M
変化(1日)
-0.30%
変化(1年)
-34.64%
MX
取引 Genomma Lab Internacional, S.A.B. de C.V. (LABB)

カテゴリー

Genomma Lab Internacional, S.A.B. de C.V.(LABB)の配当利回りの履歴
Genomma Lab Internacional, S.A.B. de C.V.(銘柄コード: LABB)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Genomma Lab Internacional, S.A.B. de C.V.(LABB)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)